These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3037450)

  • 1. Dopamine receptors mediating the stimulation and the inhibition of adenylate cyclase in rat prostate gland.
    Amenta D; Cavallotti C; Amenta F
    Neurosci Lett; 1987 Jun; 77(1):66-70. PubMed ID: 3037450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.
    Onali P; Olianas MC; Gessa GL
    Eur J Pharmacol; 1984 Mar; 99(1):127-8. PubMed ID: 6233165
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptors mediating inhibition of the cyclic adenosine monophosphate generating system in the rat renal cortex.
    Ricci A; Collier WL; Rossodivita I; Amenta F
    J Auton Pharmacol; 1991 Apr; 11(2):121-7. PubMed ID: 1675217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dopamine on the cyclic adenosine monophosphate generating system in the rabbit internal carotid and middle cerebral artery.
    Amenta D; Cavallotti C; Collier WL; De Rossi M; Ricci A; Amenta F
    Arch Int Pharmacodyn Ther; 1988; 291():96-103. PubMed ID: 2835025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postsynaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries.
    Missale C; Pizzi M; Memo M; Picotti GB; Carruba MO; Spano PF
    Neurosci Lett; 1985 Oct; 61(1-2):207-11. PubMed ID: 2867503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of rat renal medulla dopamine-sensitive cyclic adenosine monophosphate generating system.
    Amenta F; Ricci A; Vega JA
    J Pharmacol Exp Ther; 1990 Apr; 253(1):246-9. PubMed ID: 2158544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus.
    Grilli M; Nisoli E; Memo M; Missale C; Spano PF
    Neurosci Lett; 1988 May; 87(3):253-8. PubMed ID: 2898118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic receptors linked to adenylate cyclase in human cerebromicrovascular endothelium.
    Bacic F; Uematsu S; McCarron RM; Spatz M
    J Neurochem; 1991 Nov; 57(5):1774-80. PubMed ID: 1681036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lead exposure alters dopaminergic mechanisms in rat pituitary.
    Lucchi L; Govoni S; Memo M; Missale C; Spano PF; Trabucchi M
    Toxicol Lett; 1986 Sep; 32(3):255-60. PubMed ID: 3022429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
    Schoors DF; Vauquelin GP; De Vos H; Smets G; Velkeniers B; Vanhaelst L; Dupont AG
    Br J Pharmacol; 1991 Aug; 103(4):1928-34. PubMed ID: 1833020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex.
    Nisoli E; Grilli M; Memo M; Missale C; Spano PF
    Neurosci Lett; 1988 May; 87(3):247-52. PubMed ID: 2898117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum.
    Olianas MC; Onali P
    J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 dopamine receptors in the rat retina: effect of dark adaptation and chronic blockade by SCH 23390.
    Porceddu ML; De Montis G; Mele S; Ongini E; Biggio G
    Brain Res; 1987 Oct; 424(2):264-71. PubMed ID: 2960425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epinephrine and norepinephrine stimulation of adenylate cyclase in bovine retina homogenate: evidence for interaction with the dopamine D1 receptor.
    Vanderheyden P; Ebinger G; Kanarek L; Vauquelin G
    Life Sci; 1986 Mar; 38(13):1221-7. PubMed ID: 3007905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-sensitive adenylate cyclase in rabbit renal artery.
    Collier WL; Cavallotti C; de Rossi M; Amenta F
    Neurosci Lett; 1983 Dec; 43(2-3):197-202. PubMed ID: 6324039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.